SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-015503
Filing Date
2023-05-04
Accepted
2023-05-04 09:26:19
Documents
21
Period of Report
2023-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K espr-20230504.htm   iXBRL 8-K 35344
2 EX-99.1 esperionvsdseamendedcompla.htm EX-99.1 169347
3 EX-99.2 dseamendedcomplaintpressre.htm EX-99.2 18790
7 image1a.jpg GRAPHIC 549926
8 image2a.jpg GRAPHIC 1061624
9 image3a.jpg GRAPHIC 752434
10 image4a.jpg GRAPHIC 474236
11 image5a.jpg GRAPHIC 33514
12 image6a.jpg GRAPHIC 256390
13 imagea.jpg GRAPHIC 294536
  Complete submission text file 0001628280-23-015503.txt   5118438

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20230504.xsd EX-101.SCH 1915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20230504_lab.xml EX-101.LAB 24849
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20230504_pre.xml EX-101.PRE 13058
15 EXTRACTED XBRL INSTANCE DOCUMENT espr-20230504_htm.xml XML 11017
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 23886849
SIC: 2834 Pharmaceutical Preparations